Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | TUBB1 | Q9H4B7 | 9/20 | 0.62 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | FDPS | P14324 | 1/20 | 0.58 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.56 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.56 |
| ▸ | ABAT | P80404 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ERN1 | O75460 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7531959 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL29400600 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL18003049 | 0.88 | TUBB1 (0.64) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL8703222 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL2010199 | 0.85 | ERN1 (0.60) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL22387 | 0.84 | ALDH1A1 (0.68) | ALDH1A1TSHRAOX1HPGDMEN1 | |
| Cyclohexylamine SCHEMBL7792102 | 0.83 | ALDH1A1 (0.49) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL755096 | 0.83 | TTR (0.56) | ALDH1A1TSHRTUBB1AOX1HPGD | |
| SCHEMBL21402632 | 0.82 | TUBB1 (0.65) | ALDH1A1TSHRTUBB1HPGDMEN1 | |
| SCHEMBL9135637 | 0.82 | TUBB1 (0.65) | ALDH1A1TSHRTUBB1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700470-A | Scutellarin derivatives and application thereof in medicine | 中国药科大学 | 2024-03-15 | — | — | CN | claimed |
| CN-116283821-B | Phencyclized propylamine compound, preparation method and application | 郑州大学 | 2024-01-26 | — | — | CN | claimed |
| CN-116947754-A | Antitumor compound, antitumor drug, preparation method and application | 北京中医药大学 | 2023-10-27 | — | — | CN | claimed |
| CN-116283821-A | Phencyclized propylamine compound, preparation method and application | 郑州大学 | 2023-06-23 | — | — | CN | claimed |
| CN-116120182-A | Curcumin derivative, synthesis method thereof and application thereof in antiandrogen receptor | 常州大学 | 2023-05-16 | — | — | CN | claimed |
| CN-114981247-A | Piperazine compounds for inhibiting CPS1 | 卫材R&D管理有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-111690026-A | Avermectin aminophosphonate compound, preparation method thereof and application thereof in pesticides | 兰州大学 | 2020-09-22 | — | — | CN | claimed |
| US-9783537-B2 | 3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation thereof useful as potential anticancer agents | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-10-10 | — | — | US | claimed |
| US-20160222006-A1 | 3-(4-Ethylnylphenyl) Pyridopyrimidinone Compounds and Process for Preparation Thereof Useful As Potential Anticancer Agents | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-08-04 | — | — | US | claimed |
| WO-2015025326-A1 | 3-(4-ETHYNYLPHENYL) PYRIDOPYRIMIDINONE COMPOUNDS AND PROCESS FOR PREPARATION THEREOF USEFUL AS POTENTIAL ANTIC ANCER AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-02-26 | — | — | WO | claimed |
| US-7196099-B2 | Compounds and compositions as cathepsin inhibitors | AVENTIS PHARMACEUTICALS INC. (US) | 2007-03-27 | — | — | US | claimed |
| EP-1670314-A2 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | Sequella, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| US-20050113574-A1 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | SEQUELLA, INC. | 2005-05-26 | — | — | US | claimed |
| WO-2005034857-A2 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | SEQUELLA, INC. (US) | 2005-04-21 | — | — | WO | claimed |
| US-20040014796-A1 | Novel compounds and compositions as cathepsin S inhititors | AXYS PHARMACEUTICALS, INC. | 2004-01-22 | — | — | US | claimed |
| EP-1358169-A2 | DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2003-11-05 | — | — | EP | claimed |
| WO-2002057261-A2 | DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-25 | — | — | WO | claimed |
| EP-1212302-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-06-12 | — | — | EP | claimed |
| WO-2001019796-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113574-A1 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | C5, DDC, SAT1 | ALDH1A1 1171/4885TSHR 3775/4885TUBB1 394/4885 |
| US-20160222006-A1 | 3-(4-Ethylnylphenyl) Pyridopyrimidinone Compounds and Process for Preparation Thereof Useful As Potential Anticancer Agents | CBR3, HCCS, CYP3A4 | ALDH1A1 811/4885TSHR 1915/4885TUBB1 1575/4885 |
| US-20040014796-A1 | Novel compounds and compositions as cathepsin S inhititors | CTSS, CTSB, CTSE | ALDH1A1 4044/4885TSHR 3722/4885TUBB1 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.